Olema Pharmaceuticals, Inc.

OLMA · Nasdaq · SIC 2834: Pharmaceutical Preparations
94
SEC Filings

Business Summary

Part I . Overview Olema is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of next-generation targeted therapies for breast cancer and beyond. We are advancing our pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Our lead product candidate, palazestrant (formerly known as OP-1250), is a novel, orally-available small molecule with dual acti...

Next Earnings

Q2 FY2026 — expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionOLMAdiscussed_in_filing Cybersecurity
topic_mentionOLMAdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001193125-26-107169EDGAR112K words
2025-03-182024-12-310000950170-25-041204EDGAR—
2024-03-112023-12-310000950170-24-029281EDGAR—
2023-03-092022-12-310001558370-23-003318EDGAR—
2022-02-282021-12-310001558370-22-002388EDGAR—
2021-03-172020-12-310001558370-21-003141EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-273236EDGAR76K words
2025-08-112025-06-300000950170-25-106565EDGAR—
2025-05-132025-03-310000950170-25-070374EDGAR—
2024-11-122024-09-300000950170-24-125427EDGAR—
2024-08-062024-06-300000950170-24-091836EDGAR—
2024-05-082024-03-310000950170-24-055686EDGAR—
2023-11-072023-09-300001558370-23-017994EDGAR—
2023-08-082023-06-300001558370-23-013936EDGAR—
2023-05-092023-03-310001558370-23-008815EDGAR—
2022-11-082022-09-300001558370-22-016903EDGAR—
2022-08-092022-06-300001558370-22-012930EDGAR—
2022-05-092022-03-310001558370-22-007860EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-160001193125-26-107154EDGAR1K words
2026-01-300001193125-26-031792EDGAR—
2026-01-120001193125-26-010507EDGAR—
2025-11-190001193125-25-288343EDGAR—
2025-11-180001193125-25-286206EDGAR—
2025-11-100001193125-25-273228EDGAR—
2025-10-200001193125-25-243765EDGAR—
2025-09-020001750284-25-000007EDGAR—
2025-08-110000950170-25-106545EDGAR—
2025-06-130000950170-25-086256EDGAR—

94 total filings indexed. 66 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001750284
TickerOLMA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 23c2bfa8eb279bdd9142692109865f23e0c358580cda3f20e8734020275fb46d
parent: d0e62bca4422be33464edbcbcf30781d98c72f1d7f5bd03b10233716fe7089c8
content hash: 2fb11e322302042c66cb99c8ff50f10ad729097cc53ad903965271f8b89853c3
signed: 2026-04-13T04:46:42.720Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf